Autophagy and cellular senescence mediated by Sox2 suppress malignancy of cancer cells
Yong-Yeon Cho1, Dong Joon Kim, Hye Suk Lee
1College of Pharmacy, The Catholic University of Korea, Gyeonggi-do, Korea. yongyeon@catholic.ac.kr
Abstract:
Autophagy is a critical cellular process required for maintaining cellular homeostasis in health and disease states, but the molecular mechanisms and impact of autophagy on cancer is not fully understood. Here, we found that Sox2, a key transcription factor in the regulation of the "stemness" of embryonic stem cells and induced-pluripotent stem cells, strongly induced autophagic phenomena, including intracellular vacuole formation and lysosomal activation in colon cancer cells. The activation occurred through Sox2-mediated ATG10 gene expression and resulted in the inhibition of cell proliferation and anchorage-independent colony growth ex vivo and tumor growth in vivo. Further, we found that Sox2-induced-autophagy enhanced cellular senescence by up-regulating tumor suppressors or senescence factors, including p16(INK4a), p21 and phosphorylated p53 (Ser15). Notably, knockdown of ATG10 in Sox2-expressing colon cancer cells restored cancer cell properties. Taken together, our results demonstrated that regulation of autophagy mediated by Sox2 is a mechanism-driven novel strategy to treat human colon cancers.
Insights
The transcription factor Sox2 promotes autophagy in colon cancer cells by increasing ATG10 expression. This autophagy inhibits cancer cell proliferation and tumor growth, offering a potential new treatment strategy.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Biology
Background:
- Autophagy is vital for cellular homeostasis but its role in cancer remains unclear.
- Sox2 is a transcription factor regulating stemness in embryonic and induced-pluripotent stem cells.
Purpose of the Study:
- To investigate the role of Sox2 in regulating autophagy in colon cancer cells.
- To determine the molecular mechanisms and therapeutic potential of Sox2-mediated autophagy in colon cancer.
Main Methods:
- Assessed autophagic phenomena (vacuole formation, lysosomal activation) in colon cancer cells.
- Analyzed Sox2-mediated ATG10 gene expression.
- Evaluated the impact of Sox2 and ATG10 on cell proliferation, colony formation, and tumor growth in vivo.
- Investigated the effect of Sox2-induced autophagy on cellular senescence markers (p16INK4a, p21, p53).
Main Results:
- Sox2 strongly induced autophagy in colon cancer cells via ATG10.
- Sox2-induced autophagy inhibited cell proliferation, anchorage-independent growth, and tumor growth.
- Sox2-mediated autophagy enhanced cellular senescence by upregulating p16INK4a, p21, and p53.
- Knockdown of ATG10 reversed the anti-cancer effects in Sox2-expressing cells.
Conclusions:
- Sox2 regulates autophagy in colon cancer through ATG10.
- Sox2-induced autophagy inhibits colon cancer progression and promotes senescence.
- Targeting Sox2-mediated autophagy presents a novel therapeutic strategy for human colon cancers.
Related Concept Videos
Replicative Cell Senescence
Replicative Cell Senescence
Abnormal Proliferation
Cellular Injury V: Apoptosis and Autophagy
The Intrinsic Apoptotic Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

